Giuseppe Lucisano
University of Bari
EndocrinologyPhysical therapyType 2 diabetesDiabetes mellitusMedicine
What is this?
Publications 84
#1Hiddo J. Lambers Heerspink (The George Institute for Global Health)H-Index: 45
#2Avraham Karasik (TAU: Tel Aviv University)H-Index: 24
Last. Mikhail Kosiborod (UMKC: University of Missouri–Kansas City)H-Index: 46
view all 17 authors...
Summary Background Cardiovascular and kidney outcome trials have shown that sodium-glucose co-transporter-2 (SGLT2) inhibitors slow progression of chronic kidney disease in patients with type 2 diabetes with or without chronic kidney disease. The aim of this study was to assess whether these benefits extend to patients with type 2 diabetes treated in routine clinical practice. Methods CVD-REAL 3 was a multinational observational cohort study in which new users of SGLT2 inhibitors and other gluco...
8 CitationsSource
#1Paola PonzaniH-Index: 4
#2Cesare BerraH-Index: 3
Last. Maria Chiara RossiH-Index: 23
view all 8 authors...
Introduction Real-world evidence on the effectiveness and safety of insulin degludec (IDeg) in patients with diabetes is a priority. We have therefore evaluated the effectiveness and safety of IDeg, including impact on metabolic control, glycemic variability, weight gain and hypoglycemia, in patients with type 1 diabetes under routine clinical practice conditions.
#1Antonio CerielloH-Index: 76
#2Maria Chiara RossiH-Index: 23
Last. Antonio NicolucciH-Index: 55
view all 11 authors...
The affiliations listed for author Antonio Ceriello have been amended to a single affiliation note, …
#1Lucia Ferrito (Boston Children's Hospital)H-Index: 3
#2Barbara Predieri (University of Modena and Reggio Emilia)H-Index: 14
Last. V. Cherubini (Boston Children's Hospital)H-Index: 2
view all 14 authors...
Diagnosis of type 1 diabetes (T1D) in a child is often associated with anger, denial, fear, and depression from the parents. The aim of the study was to improve parents’ adaptation to the diagnosis of diabetes of their child. Sixty-two parents (29 mothers, 33 fathers) of 36 children with type 1 diabetes (;;) participated in a three-day educational working group pilot intervention study. Intervention was based on the reexamination of the traumatic event of diagnosis of T1D through spatial and tim...
1 CitationsSource
#1Damiano Paolicelli (University of Bari)H-Index: 25
#2Giuseppe LucisanoH-Index: 20
Last. Maria Trojano (University of Bari)H-Index: 55
view all 33 authors...
Background The increase in disease-modifying drugs (DMDs) allows individualization of treatment in relapsing multiple sclerosis (RMS); however, the long-term impact of different treatment sequences is not well established. This is particularly relevant for MS patients who may need to postpone more aggressive DMD strategies.
Abstract Background Gram-negative Multi-Drug-Resistant Organisms (GNMDROs) cause an increasing burden of disease in Intensive Care Units (ICUs). We deployed a multifaceted intervention to control selection and transmission of GNMDROs and to estimate at which rate GNMDROs would decline with our interventional bundle. Methods Interventions implemented in 2015: in-ward Antimicrobial-Stewardship-Program for appropriate management of antimicrobial prescription; infection monitoring with nasal/rectal ...
Abstract Background and aims Hypoglycemia represents a relevant burden in people with diabetes. Consequences of hypoglycemia/fear of hypoglycemia on quality of life (QoL) and behaviors of patients with T1DM and T2DM were assessed. Methods and results HYPOS-1 was an observational retrospective study. Fear of hypoglycemia (Fear of Hypoglycemia Questionnaire, FHQ), general health status (visual analog scale of EuroQol questionnaire, EQ5D-VAS) psychological well-being (WHO-5 well being index, WHO-5)...
1 CitationsSource
#1Alessia Manni (University of Bari)H-Index: 4
#2Antonio Iaffaldano (University of Bari)H-Index: 3
Last. Damiano Paolicelli (University of Bari)H-Index: 25
view all 9 authors...
Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body Mass Index (BMI) for treatment response in a real life setting of dimethyl fumarate (DMF) treated patients. Materials and Methods: We included in our observational analysis 338 patients who were prescribed DMF in an Italian MS Centre. We collected c...